Terremoto Biosciences
PrivateLast Round
Series C
Apr 15, 2026
Total Funding Raised
$358M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Terremoto Biosciences is a biotechnology company that develops a drug delivery and discovery platform for small-molecule medicines, enabling the creation of therapies with enhanced clinical profiles and improved therapeutic benefits for serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terremoto Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Terremoto Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 15, 2026 | ||||
| Series B | Nov 2, 2023 | ||||
| Series A | May 25, 2022 |
Terremoto Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B |
| RA Capital Management | Series C |
| Cormorant Asset Management | Series C, Series B |
| Deep Track Capital | Series C |
| Osage University Partners | Series C |
| OrbiMed | Series C, Series B, Series A |
| Cormorant Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
$108M round completed.
- Jan 10, 2025
James Christensen appointed President and Head of Research & Development.
Terremoto Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Terremoto Biosciences's valuation, stock price, and market status.